Attacq Limited (JSE:ATT) News - Resignation of a prescribed officer ATTACQ LIMITED (Incorporated in the Republic of South Africa) (Registration number 1997/000543/06) JSE share code: ATT ISIN: ZAE000177218 (Approved as a REIT by the JSE) ("Attacq" or "the company") RESIGNATION OF A PRESCRIBED OFFICER The Company announces that Mr Giles Pendleton, Attacq's Chief Development Officer and a prescribed officer of the company, has tendered his resignation with effect from 31 January 2022. Mr Pendleton and his family are leaving South Africa for Saudi Arabia. The company has accepted his resignation and would like to express sincere appreciation to him for his years of dedicated service and wishes him well in his future endeavours. In line with the company's short-term succession plan, the responsibilities of the Chief Development Officer will be fulfilled by the Chief Executive Officer, Ms Jackie van Niekerk, until such time as a suitable replacement is found. 10 December 2021 Sponsor Java Capital Date: 10-12-2021 11:05:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.